In acquired resistance to EGFR-directed treatment, high IGF1R activity has been linked to intrinsic resistance to gefitinib in NSCLC cell lines, and IGF1R shows noteworthy importance in the resistance development in cells under hypoxic conditions [17–19]. This evidence concerns the gene IGF1R and non-small cell lung carcinoma.